How big is the Plasma Protein Therapeutics Market?

The Plasma Protein Therapeutics Market size is expected to reach USD 30.49 billion in 2024 and grow at a CAGR of 5.5% to reach USD 39.85 billion by 2029. Read More

What is the current Plasma Protein Therapeutics Market size?

In 2024, the Plasma Protein Therapeutics Market size is expected to reach USD 30.49 billion. Read More

Who are the key players in Plasma Protein Therapeutics Market?

Octapharma USA Inc., Takeda Pharmaceutical Company Limited, Biotest UK, Grifols, S.A. and CSL Limited are the major companies operating in the Plasma Protein Therapeutics Market. Read More

Which is the fastest growing region in Plasma Protein Therapeutics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Plasma Protein Therapeutics Market?

In 2024, the North America accounts for the largest market share in Plasma Protein Therapeutics Market. Read More

What years does this Plasma Protein Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Plasma Protein Therapeutics Market size was estimated at USD 28.81 billion. The report covers the Plasma Protein Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Plasma Protein Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Plasma Protein Therapeutics Market - Forecast, Trends & Size

Plasma Protein Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Protein Therapeutics Market Analysis & Revenue. The Market is Segmented by Product (Immunoglobulin, Albumin, Plasma Derived Factor VL, and Other Products), Application (Hemophilia, Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiencies, and Other Applications), and Geography (North America (United States, Canada, and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and Rest of Middle East and Africa), and South America (Brazil, Argentina, and Rest of South America)). The Value is Provided in (USD Million) for the Above Segments.

Plasma Protein Therapeutics Industry Overview

In the current scenario, strategies by the market players are increasing, fueling the plasma protein therapeutics market. The market is competitive in nature due to the heavy demand for products. The plasma protein therapeutics market is moderately competitive and consists of several major players. Some companies currently dominating the market are Takeda Pharmaceutical Company Limited, Octapharma USA Inc., Biotest UK, Baxter, Grifols, S.A., and CSL, among others.